The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Embecta Corp, doing business as Berra Newco Inc., for the procurement of insulin syringes. The contract has a ceiling value of $23,217,097 and a period of performance from April 23, 2023 to April 22, 2024, with four one-year option periods. The IDC was awarded as an unrestricted procurement to provide a continuous supply of various insulin syringe configurations to support the outpatient pharmacy needs of the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract will leverage the VA and Department of Defense's Pharmaceutical Prime Vendor Programs for distribution. The solicitation outlined nine insulin syringe line items with estimated annual usage quantities ranging from 7,124 to 232,725 boxes. As an experienced federal contractor, Embecta has a history of providing medical and surgical supplies, including insulin delivery devices, to VA healthcare facilities and other government customers.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00009 | Supplemental Agreement for work within scope | $0 | 3/26/25 | |
| P00008 | Exercise an Option | $0 | 2/24/25 | |
| P00007 | Add Subcontract Plan | $0 | 10/11/24 | |
| P00006 | Other Administrative Action | $0 | 4/23/24 | |
| P00005 | Exercise an Option | $0 | 2/26/24 |
Name | Description | Solicitation Number | Federal Agency | Type | Posted Date (Click to sort descending) |
|---|---|---|---|---|---|
6515--Insulin Syringes - 36E79722R0041 | 36E79722R0041 | Department of Veterans Affairs National Acquisition Center | Pre-Solicitation 1/3 | 10/11/22, 2:24 PM | |
6515--Insulin Syringes | 36E79722R0041 | Department of Veterans Affairs National Acquisition Center | Award Notice 3/3 | 12/29/22, 2:13 PM | |
6515--Insulin Syringes - 36E79722R0041 | 36E79722R0041 | Department of Veterans Affairs National Acquisition Center | Solicitation 2/3 | 11/7/22, 12:24 PM |